Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platform (VIP) Vascular Closure Device

NCT01858636 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 235

Last updated 2019-02-05

Study results available
· View outcomes & findings →

Summary

To characterize the clinical outcomes of Angio-Seal VIP with St. Jude Medical (SJM) collagen through the collection of device/procedure-related major vascular complications and time to hemostasis.

Conditions

  • Vascular Closure

Interventions

DEVICE

Angio-Seal VIP 6 French (6F) and 8 French (8F) devices

These devices are used for the vascular closure procedure

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • Germany
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01858636 on ClinicalTrials.gov